OncoMark Ltd. is a private company centred on the development and application of biomarker panels, particularly supporting oncology drug development. A major focus of the company is to provide the link from -omic level discovery to validation via the use of multiplex antibody-based assays and high-throughput tissue microarray screening. OncoMark also conducts in-house research and development to (1) create unique multi-marker assays for use in the discrimination of patient response to drug therapies and (2) apply novel in-house image analysis toolkit for assessment of IHC-based markers at the subcellular compartmental level [IHC-MARK]. This is of particular benefit to the pharmaceutical and health authority sectors.
Company Details
- Employees
- 4
- Founded
- -
- Address
- Belfield, Dublin,ireland
- Phone
- 353 1 716 3666
- in****@****ark.com
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Website
- oncomark.com
- Keywords
- Molecular Diagnostics, Cancer, Proteomics, Companion Diagnostics, and IHC, FISH, rtPCR, ELISA.
- HQ
- Dublin
Oncomark Questions
Oncomark's helpline number is 353 1 716 3666
Oncomark's website is oncomark.com
Oncomark's LinkedIn profile is https://ie.linkedin.com/company/oncomark
Oncomark has
4 employees.
View email and phone details for 4
employees at Oncomark.
Oncomark's industry is
Biotechnology Research
Oncomark's top competitors are
Metabolomic Diagnostics,
Afimmune Ltd,
Avectas,
Orbsen Therapeutics Limited,
Onk Therapeutics,
Hitech Health,
Ds Biopharma,
Haon Life Science,
Oncoassure Ltd,
Solvotrin Therapeutics - Active Iron.
Oncomark's support email address is info@oncomark.com
Oncomark's categories are Biotechnology Research
Oncomark's founding year is 2007
